A groundbreaking LLM-assisted scoring framework identified GPNMB as a promising CAR T target for 3 cancers: melanoma, leukemia, and colorectal cancer. #CARtherapy PMID:42349381, Cell 2026, @Cell https://www.cell.com/cell/fulltext/S0092-8674(26)00652-5 #Medsky #Pharmsky #RNA #ASHG #ESHG đź§Ş
